Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02797457
Other study ID # 69HCL15_0084
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 16, 2018
Est. completion date October 16, 2031

Study information

Verified date May 2024
Source Hospices Civils de Lyon
Contact Lionel BADET, M
Phone 4 72 11 91 91
Email lionel.badet@chu-lyon.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The double amputation of the forearms is a rare handicap that seriously impacts the autonomy and the quality of life of patients, social and familial exclusion, and dependence on third parties for everyday activities. The management of these patients is nearly exclusively through the use of prostheses. Certain patients refuse this solution, or remain penalized by the absence of sensitivity , the lack of precision in movements, and body image issues related to the amputation; the double graft of hands and forearms may, in this circumstance, be the only solution. Since January 2000, date of the first double hand graft, six bilateral grafts of hands have been performed at the Hospices Civils de Lyon. This first study reported the feasibility of the graft. The functional results obtained after the double transplant have allowed patients to recover complete autonomy for everyday activities, at the price of an immunosuppressive treatment. We have found that these very good functional results are maintained over time and, for a certain number of patients, to return to work which is a factor of social integration. The rate of medical complications (metabolic, infectious, oncological), essentially related to the immunosuppressive treatment, is not greater to that found for other types of graft, but are considered as a limiting factor for the development of this strategy. These results are confirmed by international experience that is of the same order. Only a few rare cases of re-amputation have been reported in patients for whom the immunosuppressive treatment was discontinued or following vascular thrombosis. A new study is required to continue this evaluation and to compare double graft to prostheses in terms costs, quality of life, usefulness, satisfaction, autonomy, and social integration. The results of this study will allow the placement of these strategies in the management of patients with double amputation of the hands and forearms.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date October 16, 2031
Est. primary completion date October 16, 2031
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: Inclusion criteria common to the 2 groups of patients (allograft group and protheses group): - Adult aged 18 to 60 years - Double amputated of both forearms Transplant eligibility criteria (for allograft group) - Minimum interval between amputation and graft of three months (no maximal delay) - Absence of previous psychiatric history contraindicating the graft and psychological maturity, according to two psychiatrists who have evaluated the patient - No previous history of malignant tumor in remission for less than 5 years - American Society of Anesthesiology (ASA) score = 2 - New York Heart Association (NYHA) grade = 1 - Creatinine clearance = 60 ml/min/1.73m² - Absence of badly controlled sever hypertension Exclusion Criteria: - Mono amputated patients - Malignant tumor or previous history of malignant tumor for which the risk of recurrence at 5 years is greater than 5%

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Bilateral allograft of the hands and forearms.
Bilateral allograft of the hands and forearms.
Prosthetic forehands
Prosthetic forehands

Locations

Country Name City State
France Serice de Rééducation et Réadaptation fonctionnelles - Centre Jacques Calvé - Fondation Hopale Berck
France Service de Médecine Physique et Réadapatation fonctionnelle - Centre de Médecine Physique et de Réadaptation La Tour de Gassies Bruges
France Serice de Médecine Physique et Réadaptation - Hôpital d'Instruction des Armées Percy Clamart
France Serice de Rééducation et Réadaptation fonctionnelles - Centre l'Espoir Lille
France Serice de Médecine Physique et Réadaptation des patients amputés - Centre Médico-Chirugical et de Réadaptation des Massues Lyon
France Service de Chirurgie de la Transplantation - Hôpital Edouard Herriot - Hospices Civils de Lyon Lyon
France Serice de Rééducation et Réadaptation fonctionnelles - Centre Médical de Rééducation Romans Ferrari Miribel
France Service de Médecine Physique et Réadaptation - Institut Régional de Médecine Physique et de Réadaptation Nancy
France Serice de Rééducation fonctionnelle - Centre Mutualiste de Rééducation et Réadaptation fonctionnelles de Kerpape Ploemeur
France Serice de Rééducation et Réadaptation fonctionnelles - Hôpital Henry-Gabrielle - Hospices Civils de Lyon Saint-Genis-Laval
France Service de Rééducation et appareillage - Institut Robert Merle d'Aubigné Valenton

Sponsors (1)

Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Treatment cost Treatment cost of double amputated patients by bilateral allograft of the hands and forearms or by prostheses 36 months